These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Purification and some properties of kininogens in canine plasma. Mashiko H; Takahashi H Agents Actions Suppl; 1992; 38 ( Pt 1)():249-56. PubMed ID: 1466277 [TBL] [Abstract][Full Text] [Related]
4. T-kinin and T-kininogen. Greenbaum LM; Okamoto H Methods Enzymol; 1988; 163():272-82. PubMed ID: 3237079 [No Abstract] [Full Text] [Related]
5. Heavy chain of human high molecular weight and low molecular weight kininogens binds calcium ion. Higashiyama S; Ohkubo I; Ishiguro H; Sasaki M; Matsuda T; Nakamura R Biochemistry; 1987 Nov; 26(23):7450-8. PubMed ID: 3427086 [TBL] [Abstract][Full Text] [Related]
6. Ubiquinol-cytochrome-c reductase from human and bovine mitochondria. Schägger H; Brandt U; Gencic S; von Jagow G Methods Enzymol; 1995; 260():82-96. PubMed ID: 8592474 [No Abstract] [Full Text] [Related]
7. Bovine plasma kininogens. II. Microheterogeneities of high molecular weight kininogens and their structural relationships. Komiya M; Kato H; Suzuki T J Biochem; 1974 Oct; 76(4):823-32. PubMed ID: 4474169 [No Abstract] [Full Text] [Related]
9. Production and characterization of monoclonal antibodies directed against high and low molecular weight kininogens. Hentges F; Kohnen M; Grigioni F; Reichert P; Humbel R; Schneider F Bull Soc Sci Med Grand Duche Luxemb; 1994; 131(2):9-17. PubMed ID: 7820912 [TBL] [Abstract][Full Text] [Related]
11. Purification of Escherichia coli DNA polymerase III holoenzyme. Cull MG; McHenry CS Methods Enzymol; 1995; 262():22-35. PubMed ID: 8594350 [No Abstract] [Full Text] [Related]
12. Purification and characterization of acute phase rat plasma thiostatin. Rusiniak ME; Wagh PV; Bedi GS; Back N Prep Biochem; 1994 Feb; 24(1):41-59. PubMed ID: 7514789 [TBL] [Abstract][Full Text] [Related]
13. Primary structure of bovine high molecular weight kininogen: chemical compositions of kinin-free kininogen and peptide fragments released by plasma kallikrein. Han YN; Komiya M; Kato H; Iwanaga S; Suzuki T FEBS Lett; 1975 Oct; 57(3):254-8. PubMed ID: 1181197 [No Abstract] [Full Text] [Related]
14. Production and purification of cholera toxin. Mekalanos JJ Methods Enzymol; 1988; 165():169-75. PubMed ID: 3231099 [No Abstract] [Full Text] [Related]
15. Copurification of atrial natriuretic peptide receptor and particulate guanylyl cyclase. Waldman SA; Leitman DC; Murad F Methods Enzymol; 1991; 195():397-404. PubMed ID: 1674572 [No Abstract] [Full Text] [Related]
16. Preparation of human kininogen. 3. Enzymatic digestion and modification. Spragg J; Austen KF Biochem Pharmacol; 1974 Feb; 23(4):781-91. PubMed ID: 4207497 [No Abstract] [Full Text] [Related]
17. Isolation of two functionally different kininogens from human plasma--separation from proteinase inhibitors and interaction with plasma kallikrein. Habal FM; Movat HZ; Burrowes CE Biochem Pharmacol; 1974 Aug; 23(16):2291-303. PubMed ID: 4852592 [No Abstract] [Full Text] [Related]
18. Small-scale preparation of complement components C3 and C4. Dodds AW Methods Enzymol; 1993; 223():46-61. PubMed ID: 8271967 [No Abstract] [Full Text] [Related]
19. Purification of activated and heterotrimeric forms of Gq proteins. Blank JL; Exton JH Methods Enzymol; 1994; 237():174-81. PubMed ID: 7934995 [No Abstract] [Full Text] [Related]